A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 6, 2016, Pages 733-737

  Nielsen, Suzanne ^a,b   Degenhardt, Louisa ^a   Hoban, Bianca ^a   Gisev, Natasa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

Author keywords

drug utilisation; opioids; pain; pharmacoepidemiology

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIHYDROCODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; SUFENTANIL; TAPENTADOL; TRAMADOL;

ARTICLE; AUSTRALIA; CANADA; DOSE CALCULATION; DRUG FORMULATION; EUROPE; METRIC SYSTEM; ORAL MORPHINE EQUIVALENT; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES;

EID: 84973452360     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3945     Document Type: Article

References (17)

1. International Narcotics Control Board. Global opioid consumption data. Pain & Policy Studies Group, University of Wisconsin; 2011.
2. Maxwell J. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30(3): 264–270.
3. World Health Organisation. Defined daily dose: definition and general considerations. 17/12/2009 2009. Available at: http://www.whocc.no/ddd/definition_and_general_considera/ [8 November 2015].
4. Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med 2011; 25(7): 725–732.
5. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009; 38(3): 409–417.
6. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22(2): 672–687.
7. Therapeutic Guidelines limited. eTG complete: analgesic guidelines. Melbourne. 2013. Available at: http://etg.tg.com.au/complete/2013 [20 May 2014].
8. Australian Medicines Handbook. Australian Medicines Handbook. Adelaide; 2013. [20 May 2014].
9. Research Committee of the Faculty of Pain Medicine. Opioid Conversion Table. Australian and New Zealand College of Anaesthetists: Sydney, 2014.
10. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13(2): e58–e68.
11. Joint Formulary Committee. British National Formulary (BNF) 66. BMJ Publishing Group Ltd and Royal Pharmaceutical Society: London, 2013; 224.
12. UK Medicines Information (UKMi). What are the equivalent doses of oral morphine to other oral opioids when used as analgesics in adult palliative care?; 2011.
13. Lexi-comp. Drug Information Handbook (23rd edn). Lexi-comp Inc.: Ohio, 2014; 1–2422.
14. Micromedex 2.0.Truven Health Analytics, Inc. Greenwood Village, CO. Available at: http://www.micromedexsolutions.com. 2015 [28 September 2015].
15. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain – recommendations for practice version 5.6. 2010.
16. Walker P, Palla S, Pei B, et al. Switching from methadone to a different opioid: what is the equianalgesic dose ratio. J Palliat Med 2008; 11(8): 6.
17. Mercadante S, Porzio G, Aielli F, et al. Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin 2013; 29(6): 661–666.